Literature DB >> 31743578

Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis.

Sumeet K Asrani1, James Trotter1, Jack Lake2, Aijaz Ahmed3, Anthony Bonagura4, Andrew Cameron5, Andrea DiMartini6, Stevan Gonzalez7, Gene Im8, Paul Martin9, Philippe Mathurin10, Jessica Mellinger11, John P Rice12, Vijay H Shah13, Norah Terrault14, Anji Wall1, Scott Winder11, Goran Klintmalm1.   

Abstract

Liver transplantation (LT) for alcohol associated hepatitis (AH) remains controversial. We convened a consensus conference to examine various aspects of LT for AH. The goal was not to unequivocally endorse LT for AH; instead, it was to propose recommendations for programs that perform or plan to perform LT for AH. Criteria were established to determine candidacy for LT in the setting of AH and included the following: (1) AH patients presenting for the first time with decompensated liver disease that are nonresponders to medical therapy without severe medical or psychiatric comorbidities; (2) a fixed period of abstinence prior to transplantation is not required; and (3) assessment with a multidisciplinary psychosocial team, including a social worker and an addiction specialist/mental health professional with addiction and transplantation expertise. Supporting factors included lack of repeated unsuccessful attempts at addiction rehabilitation, lack of other substance use/dependency, acceptance of diagnosis/insight with a commitment of the patient/family to sobriety, and formalized agreement to adhere to total alcohol abstinence and counseling. LT should be avoided in AH patients who are likely to spontaneously recover. Short-term and longterm survival comparable to other indications for LT must be achieved. There should not be further disparity in LT either by indication, geography, or other sociodemographic factors. Treatment of alcohol-use disorders should be incorporated into pre- and post-LT care. The restrictive and focused evaluation process described in the initial LT experience for AH worldwide may not endure as this indication gains wider acceptance at more LT programs. Transparency in the selection process is crucial and requires the collection of objective data to assess outcomes and minimize center variation in listing. Oversight of program adherence is important to harmonize listing practices and outcomes.
Copyright © 2019 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 31743578      PMCID: PMC8151800          DOI: 10.1002/lt.25681

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  52 in total

Review 1.  Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria.

Authors:  Seònaid McCallum; George Masterton
Journal:  Alcohol Alcohol       Date:  2006-04-24       Impact factor: 2.826

2.  Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database.

Authors:  Brian P Lee; Gene Y Im; John P Rice; Ethan Weinberg; Christine Hsu; Oren K Fix; George Therapondos; Hyosun Han; David W Victor; Sheila Eswaran; Haripriya Maddur; Norah A Terrault
Journal:  Liver Transpl       Date:  2019-03-29       Impact factor: 5.799

3.  Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.

Authors:  Ewan H Forrest; Stephen R Atkinson; Paul Richardson; Steven Masson; Stephen Ryder; Mark R Thursz; Michael Allison
Journal:  J Hepatol       Date:  2017-11-21       Impact factor: 25.083

4.  Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis.

Authors:  Puneet Puri; George Cholankeril; Thomas Y Myint; Aparna Goel; Shiv Kumar Sarin; Ann M Harper; Aijaz Ahmed
Journal:  Alcohol Alcohol       Date:  2018-11-01       Impact factor: 2.826

5.  Epidemiology of alcoholic liver disease in Denmark 2006-2011: a population-based study.

Authors:  Thomas Deleuran; Hendrik Vilstrup; Ulrik Becker; Peter Jepsen
Journal:  Alcohol Alcohol       Date:  2015-02-13       Impact factor: 2.826

Review 6.  Current trials and novel therapeutic targets for alcoholic hepatitis.

Authors:  Ashwani K Singal; Vijay H Shah
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  Assessing priorities for allocation of donor liver grafts: survey of public and clinicians.

Authors:  J Neuberger; D Adams; P MacMaster; A Maidment; M Speed
Journal:  BMJ       Date:  1998-07-18

9.  Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.

Authors:  V Papastergiou; E A Tsochatzis; G Pieri; E Thalassinos; A Dhar; S Bruno; S Karatapanis; T V Luong; J O'Beirne; D Patch; D Thorburn; A K Burroughs
Journal:  Aliment Pharmacol Ther       Date:  2014-04       Impact factor: 8.171

Review 10.  Alcohol Relapse After Liver Transplantation for Alcoholic Cirrhosis-Impact on Liver Graft and Patient Survival: A Meta-analysis.

Authors:  Sudha Kodali; Mohamed Kaif; Raseen Tariq; Ashwani K Singal
Journal:  Alcohol Alcohol       Date:  2018-03-01       Impact factor: 2.826

View more
  15 in total

1.  Update on Liver Transplantation in Patients With Alcoholic Hepatitis.

Authors:  Christopher O'Brien
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-06

Review 2.  Early Liver Transplantation for Severe Alcoholic Hepatitis.

Authors:  Jessica L Mellinger; Jonathan G Stine
Journal:  Dig Dis Sci       Date:  2020-06       Impact factor: 3.199

3.  Integrated Care of Alcohol-Related Liver Disease.

Authors:  Gerald S Winder; Anne C Fernandez; Jessica L Mellinger
Journal:  J Clin Exp Hepatol       Date:  2022-01-31

Review 4.  Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.

Authors:  Ashwani K Singal; Paul Kwo; Allison Kwong; Suthat Liangpunsakul; Alexandre Louvet; Pranoti Mandrekar; Craig McClain; Jessica Mellinger; Gyongyi Szabo; Norah Terrault; Mark Thursz; Gerald S Winder; W Ray Kim; Vijay H Shah
Journal:  Hepatology       Date:  2021-11-27       Impact factor: 17.298

5.  Barriers for Liver Transplant in Patients with Alcohol-Related Hepatitis.

Authors:  Gina Choi; Jihane N Benhammou; Jung J Yum; Elena G Saab; Ankur P Patel; Andrew J Baird; Stephanie Aguirre; Douglas G Farmer; Sammy Saab
Journal:  J Clin Exp Hepatol       Date:  2021-09-22

6.  Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases.

Authors:  Lamia Y Haque; David A Fiellin
Journal:  Dig Dis Sci       Date:  2022-04-16       Impact factor: 3.487

7.  Positive blood phosphatidylethanol concentration is associated with unfavorable waitlist-related outcomes for patients medically appropriate for liver transplantation.

Authors:  Claire S Faulkner; Collin M White; Wuttiporn Manatsathit; Bernadette Lamb; Vatsalya Vatsalya; Craig J McClain; Loretta L Jophlin
Journal:  Alcohol Clin Exp Res       Date:  2022-03-15       Impact factor: 3.928

Review 8.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

9.  The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder.

Authors:  Michael Pimienta; Jennifer Dodge; Norah A Terrault
Journal:  Hepatol Commun       Date:  2021-02-01

Review 10.  Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis.

Authors:  Peng-Sheng Ting; Ahmet Gurakar; Jason Wheatley; Geetanjali Chander; Andrew M Cameron; Po-Hung Chen
Journal:  Clin Liver Dis       Date:  2021-05-26       Impact factor: 6.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.